China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ
0.0650
-0.05 (-41.44%)
Closed
Oct 20, 2026
Day's Range
0.06300.0700
52 wk Range
0.0400300.00
Financial Statements - SXTC - China SXT Pharmaceuticals, Inc.
Revenue
1.13M▼ 34.6%
Net Income
-6.20M▼ 87.8%Net Margin -545.2%
EBITDA
-5.99M▼ 139.6%
Free Cash Flow
-5.26M▼ 124.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 1.13M | 1.74M | 1.92M | 1.97M | 2.60M | 4.77M |
| Cost of Goods | 889.35K | 1.37M | 1.37M | 1.54M | 1.35M | 1.93M |
| Gross Profit | 248.70K | 367.42K | 553.97K | 426.27K | 1.25M | 2.83M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -7.12M | -2.68M | -2.51M | -5.60M | -5.18M | -2.19M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 980.81K | 25.04K | -39.03K | 149.51K | -181.58K | 871.65K |
| Pre Tax Income | -6.20M | -3.30M | -3.09M | -5.93M | -5.40M | -2.94M |
| Income Tax | 0 | 0 | 0 | 0 | 328.14K | -192.68K |
| Net Income | -6.20M | -3.30M | -3.09M | -5.93M | -5.73M | -2.74M |
| EPS Basic | - | -2.88K | -134.71K | -15.57K | -137.918 | -95.475 |
| EPS Diluted | - | -2.88K | -134.71K | -15.57K | -137.918 | -95.475 |
| Basic Shares Outstanding | - | 1.14K | 23 | 381 | 41.59K | 28.78K |
| Diluted Shares Outstanding | - | 1.14K | 23 | 381 | 41.59K | 28.78K |
| Ebit | -6.14M | -2.65M | -2.55M | -5.45M | -5.37M | -2.19M |
| Ebitda | -5.99M | -2.50M | -2.28M | -5.20M | -5.05M | -1.85M |
| Net Income Continuous Operations | -6.20M | -3.30M | -3.09M | -5.93M | -5.73M | -2.74M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
